14 Edelman JL, Castro MR, Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci ,1999;40(6):1112-1123

15 Harkness KA, Adamson P, Sussman JD, Davies-Jones GA, Greenwood J, Woodroofe MN. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain ,2000;123(Pt 4):698-709

16 Ryan SJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc ,1979;77:707-745

17 Dobi ET, Puliafito CA, Destro M. A new model of experimental choroidal neovascularization in the rat. Arch Ophthalmol ,1989;107(2):264-269

18许建华,张唅,刘哲丽,李若溪,孔伟,张薇.曲安奈德和血管内皮生长因子在幼鼠增生性视网膜病变中的作用.国际眼科杂志,2006;6(3):587-590

19许建华,刘哲丽,李若溪,孔炜,张薇.曲安奈德对缺氧条件下恒河猴脉络膜视网膜内皮细胞VEGF表达的影响.国际眼科杂志,2006;6(5):1053-1055

20 Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina ,2000;20(3):244-250

21 Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol ,2001;119(2):399-404

22 Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol ,1992;110(8):1155-1159

23 Castro MR, Lutz D, Edelman JL. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovescularization. Exp Eye Res ,2004;79(2): 275-285

24 Edelman JL, Castro MR. Quantitative image analysis of laser induced choroidal neo- vascularization in rat. Exp Eye Res ,2000;71(5):523-533

25 Ni M, Holland M, Jarstadmarken H, De Vries G. Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation. Exp Eye Res ,2005;81(3):286-297

26 Murata T, He S, Hangai M, Ishibashi T, Xi XP, Kim S, Hsueh WA, Ryan SJ, Law RE, Hinton DR. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Invest Ophthalmol Vis Sic, 2000;41(8):2309-2317

27 Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol ,2003;121(5):667-673

28 Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol ,2003;87(4):462-468

29 Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovasculariztion. Ophthalmology ,2003;110(8):15717-15725

30 Martidis A, Miller DG, Ciulla TA, Danis RP, Moorthy RS. Corticosteroids as antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther ,1999;15(5):425-428

31 Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularization in young patients. Eye ,1998;12(Pt 2):766-772

32 Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sic ,2001;42(1):283-290

33 D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina ,2003;23(1):14-23

34 Ciulla TA, Criswell MH, Danis RP, Fronheiser M, Yuan P, Cox TA, Csaky KG, Robinson MR. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br J Ophthalmol ,2003;87(8):1032-1037

上一页  [1] [2] [3] [4] [5] [6]